Using research to inform policy often involves reading scientific articles in costly books and journals. But for some policymakers and analysts these costs may be prohibitively expensive, leaving them without access to critical information.
Proponents of the use of randomized controlled trials (RCTs) in impact evaluation and development research often point out the close link between these trials and their clinical counterparts in the world of medical research.
